Gene: environment interaction in lipid metabolism and effect on coronary heart disease risk

被引:25
|
作者
Talmud, PJ [1 ]
Humphries, SE [1 ]
机构
[1] UCL Royal Free & UCL Med Sch, British Heart Fdn Labs, London WC1E 6JJ, England
关键词
D O I
10.1097/00041433-200204000-00006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both genetic and environmental factors influence coronary heart disease, therefore studies of coronary heart disease risk are often confounded by gene: gene and gene: environment interactions. Such interactions imply that at the molecular level there is synergy between the gene products or with the by-products of the environmental insult, resulting in a greater than additive effect on risk. Genetic risk is thus modifiable in an environment-specific manner, This review focuses on recently reported effects of smoking (environmental factor) on the impact of variation in the genes for glutathione S-transferase, paraoxonase and apolipoprotein E on the risk of coronary heart disease and effects on intermediate lipid traits. We end on a cautionary note for the need for repeat studies to confirm these reported gene: environment effects. Curr Opin Lipidol 13:149-154, (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 50 条
  • [41] The gut microbiota and lipid metabolism: Implications for human health and coronary heart disease
    Fava, F.
    Lovegrove, J. A.
    Gitau, R.
    Jackson, K. G.
    Tuohy, K. M.
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (25) : 3005 - 3021
  • [42] Do lipid lowering drugs reduce the risk of coronary heart disease?
    Pritzker, LB
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1998, 35 (06) : 603 - 621
  • [43] Advanced Lipid Testing Uncovers Residual Coronary Heart Disease Risk
    Stock, Eveline O.
    Schaefer, Ernst J.
    Kate, Creasy T.
    He, Lihong
    Diffenderfer, Margaret R.
    Asztalos, Bela F.
    Kane, John P.
    CIRCULATION, 2019, 140
  • [44] DETERMINING LIPID RISK-FACTORS FOR CORONARY HEART-DISEASE
    GELSKEY, DE
    FOX, JG
    HAMMOND, GW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1989, 140 (05) : 493 - 493
  • [45] Global risk assessment for lipid therapy to prevent coronary heart disease
    Nass C.M.
    Wiviott S.D.
    Allen J.K.
    Post W.S.
    Blumenthal R.S.
    Current Cardiology Reports, 2000, 2 (5) : 424 - 432
  • [46] JOINT LIPID RISK-FACTORS AND CORONARY HEART-DISEASE
    AUSTIN, MA
    CIRCULATION, 1992, 85 (01) : 365 - 367
  • [47] Predicting coronary heart disease risk using multiple lipid measures
    Everett, CJ
    Mainous, AG
    Koopman, RJ
    Diaz, VA
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (08): : 986 - 988
  • [48] Drug metabolism and liver disease: a drug-gene-environment interaction
    Zgheib, Nathalie K.
    Branch, Robert A.
    DRUG METABOLISM REVIEWS, 2017, 49 (01) : 35 - 55
  • [49] ATRIAL PACING IN CORONARY HEART DISEASE - EFFECT ON HEMODYNAMICS, METABOLISM AND CORONARY CIRCULATION
    FORRESTE.JS
    HELFANT, RH
    PASTERNA.A
    AMSTERDA.EA
    MOST, AS
    KEMP, HG
    GORLIN, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1971, 27 (03): : 237 - +
  • [50] A gene mutation which contributes to coronary heart disease risk
    Meleady, R
    Gallagher, P
    Shields, D
    McMaster, D
    Evans, A
    Rozen, R
    Graham, I
    Whitehead, AS
    HEART, 1996, 75 (05) : 127 - 127